BlossomHill Therapeutics

BlossomHill Therapeutics is developing small molecule therapeutics for unmet medical needs in oncology and autoimmune diseases. Founded by renowned drug design and development scientist, J. Jean Cui, and biotech veteran Y. Peter Li, BlossomHill is leveraging the golden age of bringing precision cancer therapy to patients with actionable mutations. Proceeds from their funding rounds will be used by BlossomHill to fund the research and development efforts and advance lead pipeline projects into clinical development. With this approach, BlossomHill will address urgent unmet medical needs through deeper science, true originality and rich experience from proven track record of successes.

Jobs: